Industry-Expert Theater
Hall C, #2300
The Industry-Expert Theater is the setting for hour-long presentations from industry leaders sharing the latest in cardiovascular practices, products, services and technologies. ACC provides refreshments or lunch to Theater attendees while you learn from industry leaders, including: Abbott Vascular; Accumetrics, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Medtronic, Inc.; Panasonic Healthcare; and ZOLL.
Presentation schedule is current as of Feb. 4, 2011, and is subject to change. Please check the ACC.11 ExpoGuide and ExpoGuide Addendum, available at the Expo Hall entrances and in your Official Meeting Bag, for more updated information.
Sunday, April 3
10:15 a.m.–11:15 a.m.
Pradaxa® (dabigatran etexilate mesylate) Capsules
Gerald V. Naccarelli, MD—Bernard Trabin Chair in Cardiology, Professor of Medicine, Chief, Division of Cardiology, Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center; Hershey, PA
Sunday, April 3
12:30 p.m.–1:30 p.m.
Cardiac Resynchronization Therapy:
Strong, Consistent Evidence…So What Are the Barriers?
Indications and Device Selection
Thomas Heywood, MD—Scripps Clinic; La Jolla, CA
Defibrillation Therapy and Shock Reduction
Hafiza Khan, MD—The Heart Hospital Baylor, Arrhythmia Management; Plano, TX
Heart Failure Device Diagnostics
Sanjeev Gulati, MD—Sanger Heart & Vascular Institute; Charlotte, NC
Several large randomized trials show morbidity/mortality benefits of cardiac resynchronization therapy (CRT), along with quality of life improvement. Despite these consistent results, more than 60% of patients eligible for CRT do not receive it. Join us to find out what barriers exist today and approaches to identify and assess eligible patients.
Sunday, April 3
3:45 p.m.–4:45 p.m.
Post-MI SCA Risk and Screening—The Role of the Wearable Defibrillator
Ralph J. Verdino, MD—Director, Cardiology Electrophysiology Fellowship Program, Cardiac Arrhythmia Program, Penn Heart and Vascular Center, University of Pennsylvania; Philadelphia, PA
Clinical experts will discuss the role of the wearable defibrillator in the treatment of patients at risk of sudden cardiac arrest (SCA). Discussion will include treatment options for patients post-MI, including post-PCI/CABG, during the recovery period when the patient’s SCA risk is temporary or changing.
Monday, April 4
9:45 a.m.–10:45 a.m.
Assessing Platelet Reactivity Testing in Clinical Practice:
Application of the Available Data
Current Perspectives on Assessing Response to Antiplatelet Therapies
Paul A. Gurbel, MD—Director, Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore; Associate Professor of Medicine, Johns Hopkins University School of Medicine; Baltimore, MD
Lessons Learned from GRAVITAS
Matthew J. Price, MD, FACC, FSCAI—Director, Cardiac Catheterization Laboratory, Scripps Clinic; Assistant Professor, Scripps Translational Science Institute; La Jolla, CA
Monday, April 4
12:30 p.m.–1:30 p.m.
Dual Antiplatelet Therapy: Updates and Advancements
Dual Antiplatelet Therapy Duration: Facts and Controversies
Laura Mauri, MD, MSc—Associate Professor of Medicine, Brigham and Women’s Hospital, Harvard Medical School
A New Decade of Innovation: Dual Antiplatelet Discussion: ARC, BARC, Current DAPT Guidelines and PARIS Registry
Roxana Mehran, MD—Professor of Medicine, Mount Sinai Hospital; New York, NY
Dual Antiplatelet Therapy Interruptions
Samin K. Sharma, MD—Professor of Medicine, Mount Sinai Hospital; New York, NY
A lunch discussion focused on DAPT update and advances for the clinical and interventional cardiologist. Our faculty will look at current guidelines for DAPT in DES and BMS use, review current clinical trials and discuss DAPT interruption.
Monday, April 4
3:45 p.m.–4:45 p.m.
Carotid IMT and Plaque in the Latest Guidelines for Risk Assessment of Asymptomatic Adults: Are Your Intermediate Risk Patients Adequately Evaluated and Treated?
Allen J. Taylor, MD, FACC, FAHA—Director of Advanced Cardiovascular Imaging, Washington Hospital Center, Washington, DC; Professor of Medicine, Uniformed Services University School of Medicine; Bethesda, MD
Please note that presentations in the Industry-Expert Theater do not qualify for continuing medical education (CME/CNE/CE) credit.
Please note: Industry-Expert Theater presentations are not part of the official ACC Annual Scientific Session and/or the American College of Cardiology’s Innovation in Intervention: i2 Summit in Partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.